Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.150

+0.040 (3.60%)

At close: Sep 5, 2025, 4:00 PM

1.160

+0.010 (0.87%)

After-hours: Sep 5, 2025, 7:37 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Allogeneic T Cell Therapies	22.00K	Log In	Log In	Log In
Allogeneic T Cell Therapies Growth	-76.84%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	22.00K	Log In	Log In	Log In
United States Growth	-76.84%	Log In	Log In	Log In